JPMorgan’s Billion Strategy Call Signals Bitcoin Fault Line
A JPMorgan client note argues that Strategy may purchase as much as $30 billion of Bitcoin in 2026, placing Bitcoin i...
Compare retirement index funds to see which has the lowest fees while meeting your risk and diversification goals.
28,038 articlesA JPMorgan client note argues that Strategy may purchase as much as $30 billion of Bitcoin in 2026, placing Bitcoin i...
Two NASA contract wins have put Intuitive Machines on investors’ radar, but do they move the needle for long-term ret...
Cathie Wood's Ark Invest has been quietly loading up on Nvidia this week. Here are three solid reasons why her buying...
Investors are buzzing about Revolution Medicines this year as its RAS-focused cancer programs advance. This article l...
Bitcoin extended a retreat as investors moved cash from crypto into equities ahead of SpaceX's anticipated mega IPO. ...
A decade of reinvested dividends can turn a modest $1,000 investment in Chevron into a much larger nest egg, even as ...
As June trading hits mid-month, investors eye three mega-cap cloud leaders for renewed growth and long-term backlog s...
As Disney readies Toy Story 5, investors wonder if this beloved IP can spark a broader upswing. This piece breaks dow...
San Francisco-based Peregrine Technologies locked in a $250 million Series D as it readies its platform for the 2026 ...
SpaceX kicked off a $25 billion bond offering just weeks after a historic $75 billion IPO, while its stock trades wel...
Investors often wonder if a smaller company can replicate Berkshire Hathaway’s long-term success. This analysis looks...
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...